ClaroNav Dental, a leading provider of digital dental solutions, has announced that its innovative MicronMapper photogrammetry system has received CE-mark certification, clearing the way for its sale across Europe. The milestone represents a significant step forward in ClaroNav’s mission to provide cutting-edge tools designed to enhance the precision and efficiency of dental procedures globally. The MicronMapper is ClaroNav’s next-generation photogrammetry system, created to streamline dental implant workflows and improve clinical outcomes. Designed with both functionality and ease of use in mind, the lightweight system enables dental professionals to capture highly detailed and accurate implant positions. The result is more predictable…
Author: Humanima
Zendesk has launched a range of new AI-driven solutions aimed at enhancing collaboration between human agents and artificial intelligence. The updates include AI-powered agents for omnichannel support, an improved agent copilot, voice AI capabilities, and an AI agent builder, all designed to boost customer service efficiency and improve user experiences. The new offerings are intended to help companies deliver high-quality service at scale, providing personalised and efficient interactions. As AI becomes increasingly integrated into customer service, Zendesk’s innovations demonstrate its commitment to helping businesses improve operations and drive meaningful business outcomes. Improving Service Quality and Reducing Costs Tom Eggemeier, CEO…
A new global study by Mars has highlighted a critical need for increased pet adoption, revealing that only 11% of dog owners and 17% of cat owners worldwide choose to adopt from shelters. This comes as 362 million cats and dogs remain homeless across the globe, creating a growing demand for adoption efforts, particularly in the UK. As part of its first-ever Global Adoption Weekend, running from 11th to 13th October, Mars is urging pet owners to consider adopting rescue animals. To raise awareness, much-loved television personality Fred Sirieix has teamed up with Battersea, one of the UK’s leading animal…
TPG Telecom has significantly ramped up its efforts to protect customers from AI-driven scam and spam calls, thanks to the introduction of advanced machine learning technology from network software provider Mavenir. The Australian telecoms company, which operates Vodafone, TPG, iiNet, and felix brands, has seen a 280% increase in the number of fraudulent calls blocked before they reach its mobile users. Mavenir’s CallShield solution, introduced earlier this year, has already made a substantial impact. In the first six months of 2024 alone, the technology blocked nearly 19 million fraudulent mobile calls, averaging 103,000 illicit calls per day. This marks a…
Research commissioned by Roche has revealed that half of respondents across 12 countries in Latin America and Europe have little or no awareness of the role human papillomavirus (HPV) plays in cervical cancer. The study, conducted by GWI, shows a significant knowledge gap, despite HPV being responsible for over 99% of cervical cancer cases globally. HPV is a common sexually transmitted virus and the leading cause of cervical cancer, which affects more than 600,000 women each year, resulting in over 340,000 deaths. Most of these cases occur in low-resource countries, where access to healthcare is limited. The World Health Organization…
KURE Oxygen Water, a revolutionary new bottled water, has achieved Informed Sport certification, making it a safe and reliable choice for elite athletes. The Informed Sport programme is a globally recognised quality assurance scheme for sports supplements and nutritional products. It ensures that products are free from substances banned in sport, offering the highest level of quality control by testing every batch. KURE Oxygen Water represents a major innovation in bottled water. Developed using patented technology in the UK, KURE infuses high-quality spring water with stabilised oxygen, an achievement that has long been considered impossible. The company claims that KURE…
Hansa Biopharma AB has announced promising results from a 12-month follow-up analysis of its investigational drug, HNSA-5487, as part of the NICE-01 trial. The drug is designed to cleave immunoglobulin G (IgG), a key antibody linked to several autoimmune diseases. In the trial, HNSA-5487 demonstrated rapid and robust reductions in IgG levels, lowering them by more than 95% just hours after treatment. Twelve months later, the follow-up analysis confirmed that IgG levels returned to normal six months post-dosing. These findings mirror the results seen with Hansa’s first-generation IgG-cleaving enzyme, imlifidase. No serious side effects were reported during the trial, with…
In the world of leadership, effective communication often transcends traditional task-based approaches, a notion brought to light by executive coach Sarah Langslow in her new book, Do Sweat The Small Stuff. This practical handbook delves into the crucial role of micro-interactions in shaping relationships and enhancing leadership effectiveness. Langslow argues that while meeting organisational goals is essential, it is the everyday interactions between leaders and their teams that ultimately drive individual and collective performance. She emphasises that leaders who overlook these daily exchanges may struggle to cultivate the trust and engagement needed for both task completion and broader strategic changes.…
A new initiative to support women in male-dominated industries has been launched by Diversity in the Boardroom Ltd. The six-month coaching program, named ‘Woman Up’, is designed to help women break through barriers in sectors where they remain underrepresented, such as tech, finance, and engineering. The need for such programs is underscored by the stark statistics on gender diversity in the workplace. Globally, only 29% of senior management positions are held by women, and just 8% of Fortune 500 companies are led by female CEOs. In the tech sector, women make up 26% of the workforce, while in engineering and…
A terminally ill mother from Heanor, Derbyshire, faces an uphill battle to fulfil her dream of visiting family in New York, as high travel insurance costs threaten to derail the trip. Susan Williams, 64, has been battling stage 4 small cell lung cancer since June last year, and while her fighting spirit has kept her going, her hopes of seeing long-lost relatives now hang in the balance. Despite never having met her American family, Susan had planned to visit them before the pandemic struck. Now, with her health deteriorating, she’s desperate to make what she describes as her “one last…
